The Optimal Treatment for Haemophiliacs Who Have Developed Factor VIII or -IX Antibodies

Authors :: Amy D. Shapiro
Evelien P. Mauser-Bunschoten
Erik Berntorp
Doreen B. Brettler
C P Engelfriet
O P Smith
Claude Negrier
H. W. Reesink
P M Mannucci
Alessandro Gringeri
Jørgen Ingerslev
Other departments
Source :: Vox sanguinis, 78(4), 256-261. Wiley-Blackwell
Publication Year :: 2000
Publisher :: Wiley, 2000.

Subjects :: Oncology
medicine.medical_specialty
Hematology
biology
business.industry
Optimal treatment
General Medicine
Surgery
Text mining
Internal medicine
medicine
biology.protein
Antibody
business

Full Text Access

Tools